Velsecorat is a selective glucocorticoid receptor modulator under clinical investigation. It has been studied in a clinical trial for administration via inhalation in patients with mild to moderate asthma.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1196509-60-0
Sapitinib difumurate
pharmaceutical raw material
Cis-tranexamic acid
pharmaceutical raw material
Tranexamic acid
pharmaceutical raw material
Phentermine hydrochloride
pharmaceutical raw material
3-[5-[(1S,2R)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1-yl]-N-[(3R)-oxolan-3-yl]benzamide
ZZWJKLGCDHYVMB-XGBAOLAVSA-N
C[C@H]([C@H](C1=CC2=C(C=C1)OCCO2)OC3=CC4=C(C=C3)N(N=C4)C5=CC=CC(=C5)C(=O)N[C@@H]6CCOC6)NC(=O)C(C)(F)F